Of course, considering Neuren's situation / pipeline / results to date, the company will base a fair T/O price on a DCF valuation. Isn't that a no brainer?
Whether any other side would come to the party is another matter, especially if there is a huge discrepancy between DCF & SP - which would almost certainly be the case.
- Forums
- ASX - By Stock
- The Whens and Whys of Top Biotech M&A Deals
Of course, considering Neuren's situation / pipeline / results...
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.26 |
Change
-0.220(1.42%) |
Mkt cap ! $1.947B |
Open | High | Low | Value | Volume |
$15.20 | $15.33 | $15.02 | $5.545M | 364.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 170 | $15.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.26 | 15 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 380 | 15.220 |
6 | 673 | 15.210 |
8 | 1298 | 15.200 |
6 | 777 | 15.190 |
6 | 1566 | 15.180 |
Price($) | Vol. | No. |
---|---|---|
15.240 | 383 | 8 |
15.250 | 889 | 9 |
15.260 | 552 | 4 |
15.270 | 1519 | 7 |
15.280 | 728 | 5 |
Last trade - 15.14pm 22/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online